| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63304-440-09 | 63304-440 | HUMAN PRESCRIPTION DRUG | RISEDRONATE SODIUM | RISEDRONATE SODIUM | TABLET, DELAYED RELEASE | ORAL | 20190710 | N/A | ANDA | ANDA203925 | Sun Pharmaceutical Industires Inc. | RISEDRONATE SODIUM | 35 mg/1 | 1 DOSE PACK in 1 CARTON (63304-440-09) / 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (63304-440-11) |
| 16714-870-02 | 16714-870 | HUMAN PRESCRIPTION DRUG | Risedronate Sodium | Risedronate Sodium | TABLET, DELAYED RELEASE | ORAL | 20190814 | 20250228 | ANDA | ANDA203925 | NorthStar RxLLC | RISEDRONATE SODIUM | 35 mg/1 | 1 DOSE PACK in 1 CARTON (16714-870-02) / 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (16714-870-01) |